Carrageenan induced phosphorylation of Akt is dependent on neurokinin-1 expressing neurons in the superficial dorsal horn.

Abstract

BACKGROUND:

Paw carrageenan induces activation of phosphatidylinositol 3-kinase (PI-3K) and Akt in dorsal horn neurons in addition to induction of pain behavior. Spinal PI-3K activation is also thought to be required for inflammation-induced trafficking of GluA1, AMPA receptor subunits, into plasma membranes from cytosol. Phosphorylation of Akt has a unique time course. It occurs first in the superficial dorsal horn (0.75 h), then soon dissipates and is followed an hour later by Akt phosphorylation in deeper dorsal horn laminae, primarily lamina V. Initially, we wished to determine if Akt phosphorylation in the deeper laminae were dependent on the presence of lamina I, neurokinin receptor bearing projection neurons. As the study progressed, our aims grew to include the question, whether carrageenan-induced GluA1 subunit trafficking was downstream of Akt phosphorylation.

RESULTS:

Rats pretreated with spinal saporin conjugated to a stabilized form of substance P had substantial loss of neurons with neurokinin 1 receptors throughout their superficial, but not deep dorsal horns. Animals pre-treated with substance P-saporin exhibited no change in locomotor ability and a small, but significant decrease in carrageenan-induced mechanical allodynia when compared to animals pre-treated with spinal saporin alone. Importantly, carrageenan-induced phosphorylation of Akt was blocked, in the substance P-saporin treated group, throughout the spinal cord grey matter. In marked contrast, carrageenan induced-trafficking of the GluA1 receptor subunit increased equivalently in both treatment groups.

CONCLUSIONS:

We infer from these data that 1) phosphorylation of Akt in the deep dorsal horn is dependent on prior activation of NK1 receptor bearing cells in superficial dorsal horn, and 2) there are parallel spinal intracellular cascades initiated by the carrageenan injection downstream of PI-3K activation, including one containing Akt and another involving GluA1 trafficking into neuronal plasma membranes that separately lead to enhanced pain behavior. These results imply that the two pathways downstream of PI-3K can be activated separately and therefore should be able to be inhibited independently.

• Authors: Jeong I L Choi, Fred J Koehrn, Linda S Sorkin
• Journal: Molecular pain (Mol Pain) Vol. 8 Pg. 4 (Jan 13 2012) ISSN: 1744-8069 [Electronic] United States
• PMID: 22243518 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• Receptors, AMPA
• Receptors, Neurokinin-1
• Ribosome Inactivating Proteins, Type 1
• substance P-saporin
• Substance P
• Carrageenan
• Proto-Oncogene Proteins c-akt
• Saporins
• glutamate receptor ionotropic, AMPA 1

Topics

• Animals
• Behavior, Animal (drug effects)
• Carrageenan
• Lumbar Vertebrae (drug effects, metabolism, pathology, physiopathology)
• Male
• Models, Biological
• Motor Activity (drug effects)
• Phosphorylation (drug effects)
• Posterior Horn Cells (drug effects, enzymology, pathology, physiopathology)
• Proto-Oncogene Proteins c-akt (metabolism)
• Rats
• Receptors, AMPA (metabolism)
• Receptors, Neurokinin-1 (metabolism)
• Ribosome Inactivating Proteins, Type 1 (pharmacology)
• Rotarod Performance Test
• Saporins
• Substance P (analogs & derivatives, pharmacology)